10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

7th - 8th November 2026 | Cannes, France

International Conference on Hematology and Genetic Disorders (ICHGD - 26)

4

Days

4

Hrs

07

Min

02

Sec

Conference Program

Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

Why it matters

SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 16 — Peace, Justice and Strong Institutions
Explore All Session Tracks
Track 01
Advancements in Molecular Diagnostics for Hematological Disorders

This track will explore the latest innovations in molecular diagnostic techniques that enhance the detection and characterization of hematological disorders. Emphasis will be placed on the integration of genomic technologies in clinical practice.

Track 02
Translational Research in Hematology: Bridging Bench to Bedside

This session will focus on the translation of laboratory findings into clinical applications for hematological diseases. Discussions will include successful case studies and the challenges faced in implementing translational research.

Track 03
Clinical Trials in Hematology: Design and Implementation

This track will examine the methodologies and ethical considerations involved in designing and conducting clinical trials for hematological treatments. Participants will gain insights into recent trial outcomes and their implications for patient care.

Track 04
Innovative Therapeutic Strategies for Genetic Blood Disorders

This session will highlight novel therapeutic approaches for managing genetic disorders affecting the hematological system. Topics will include gene therapy, targeted therapies, and the role of personalized medicine.

Track 05
Biomarker Discovery in Hematology: Current Trends and Future Directions

This track will delve into the identification and validation of biomarkers relevant to hematological conditions. The focus will be on how these biomarkers can improve diagnosis, prognosis, and treatment strategies.

Track 06
Patient Care in Hematology: Best Practices and Innovations

This session will discuss the latest advancements in patient care for individuals with hematological disorders. Emphasis will be placed on multidisciplinary approaches and patient-centered care models.

Track 07
Laboratory Techniques in Hematology: Enhancements and Challenges

This track will cover the latest laboratory techniques used in the diagnosis and monitoring of hematological disorders. Participants will discuss the challenges faced in standardizing these techniques across different settings.

Track 08
Genetic Insights into Hematological Malignancies

This session will focus on the genetic underpinnings of hematological malignancies, including leukemias and lymphomas. Discussions will include the role of genetic mutations in disease progression and treatment response.

Track 09
Integrating Genomics into Hematology Practice

This track will explore the integration of genomic data into routine hematology practice for improved patient outcomes. Topics will include the challenges of data interpretation and the implications for personalized treatment plans.

Track 10
Emerging Therapies in Hematology: A Focus on Novel Agents

This session will highlight emerging therapeutic agents and their mechanisms of action in the treatment of hematological disorders. Participants will discuss the potential impact of these therapies on clinical practice.

Track 11
Ethical Considerations in Hematology Research and Practice

This track will address the ethical challenges faced in hematology research and clinical practice. Discussions will include informed consent, patient autonomy, and the implications of genetic testing.

2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.